MARGARET R. ANDERSON

Statistics

Publications

Citations

892

H-Index

Active since

1986

Affiliations

Pfizer (United States)(Current)

Institute of Medicinal Plant Development

MARGARET R. ANDERSON is an author at Pfizer (United States) specializing in antibacterial pharmacology, medicinal chemistry, and antibiotic resistance.

Publications per year

1986–1991

Publications

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

James A. Retsema, Agnès Girard, W Schelkly et al. · Antimicrobial Agents and Chemotherapy · 1987 · 461 citations

Medicine, Infectious Diseases, Medicinal Chemistry +11

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 238 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection

James A. Retsema, A. R. English, Agnès Girard et al. · Clinical Infectious Diseases · 1986 · 106 citations

Life Sciences, Microbiology, Pharmacology +17

Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones. A new class of .BETA.-lactamase inhibitors.

Yuhpyng L. Chen, Cnm-Wu CHANG, K. HEDBERG et al. · The Journal of Antibiotics · 1987 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents

Thomas D. Gootz, James A. Retsema, Agnès Girard et al. · Antimicrobial Agents and Chemotherapy · 1989 · 37 citations

Life Sciences, Infectious Diseases, Microbiology +12

1–5 of 6